SAN DIEGO--Sequenom has hired Charles Rodi as vice-president, molecular biology, and Paul Heaney as vice-president of advanced systems. Both will report to Charles Cantor, the company's chief scientific officer. Rodi, who had been director of Monsanto's Genomic Sequencing Center, will oversee the advancement of automated assay development systems, such as assays for cost-effective single-nucleotide polymorphism discovery and scoring at Sequenom. Heaney's previous post was at Orchid Biocomputer, as senior director of new technology. In his new role, he will be responsible for R&D of new technologies associated with Sequenom's proprietary DNA MassArray systems.
The company recently received a patent from the US Patent and Trademark Office for its DNA mass array technology, entitled "Bead Linkers for Immobilizing Nucleic Acids to Solid Supports."